Page 21 - 112中文衛福年報簡介

2023 Taiwan Health and Welfare Report Introduction

中派案窗口，優化各項保護服務 families, and relevant service systems, the Ministry has established a
centralized case management system. This initiative aims to optimize
流程及時效品質管控機制，串接
the processes and time spent to ensure the quality control of
多樣風險資訊，評估兒少、老人
various protective services, while integrating diverse risk information.
與身心障礙者之保護及風險因子，
Assessments are conducted to evaluate the protection and risk
提供多元處遇服務，並依需求積
factors for children, the elderly, and individuals with disabilities.
極布建相關服務資源，以增進保 Multiple intervention services are provided, and relevant service
護服務品質與量能，落實保障被 resources are actively deployed based on demand, with the aim
害人及其家庭之安全與福祉。 of enhancing the quality and capacity of protective services and
ensuring the safety and well-being of victims and their families.

研究發展與

國際合作

Research, Development and
International Cooperation

111 年度衛生福利科技研究預算約 In 2022, the Ministry of Health and Welfare had 4.72 billion NTD in
budget for technological development. It has been spent in three
47.2 億元，分別投入三大面向：任
main areas: 1. task-oriented empirical research, 2. development
務導向型的實證政策研究、創新及
of innovative and translational research and 3. Health and welfare
轉譯研究、衛福資料統計應用。
statistics use.
任務導向的實證研究面向包括民
Task-oriented empirical research includes health promotion for
眾健康促進、食品藥物管理、中
people, food and drug management, Chinese medicine research
醫藥研發與推廣、精進醫療照護
and development and promotion, refining of healthcare and policies,
及 政策、 強 化全 民 健 康保 險 體
reinforcing national healthcare insurance, infectious disease prevention
制、傳染病防治與完善福利服務 and control, and improving the welfare service system.
體系。
Innovative and interpretation research includes patent technology
創新及轉譯研究面向包括專利技術
licensing, response COVID-19, and promotion of cancer translational
授權、因應嚴重特殊傳染性肺炎 research.
(COVID-19)及推動癌症轉譯研究。
Statistical application of health and welfare application includes
衛福資料統計應用面向包括應用
applied service platform management, statistics for platform service
服務平臺管理、平臺服務量能統 efficiency, and promotion of statistics-oriented biomedicine R&D.

計及推動以數據為導向之生醫研 MOHW further conducted cross-agency (Ministry of Science and

19